Ponazuril

From Self-sufficiency
Jump to: navigation, search
Ponazuril
File:Ponazuril.png
Systematic (IUPAC) name
1-Methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione
Clinical data
Routes of
administration
Oral
Legal status
Legal status
Identifiers
CAS Number 69004-04-2
ATC code none
PubChem CID 3050408
Chemical data
Formula C18H14F3N3O6S
Molar mass 457.380 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.